Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease.

作者: Kristin Aaser Lunde , Janete Chung , Ingvild Dalen , Kenn Freddy Pedersen , Jan Linder

DOI: 10.1016/J.JALZ.2018.04.006

关键词: GlucocerebrosidaseDementiaSurvival analysisParkinson's diseaseGenetic associationNeurologyInternal medicineHazard ratioMedicineConfidence interval

摘要: Abstract Introduction Both polymorphisms and mutations in glucocerebrosidase ( GBA ) may influence the development of dementia patients with Parkinson's disease. Methods Four hundred forty-two 419 controls were followed for 7 years. Dementia was diagnosed using established criteria. Participants analyzed genetic variants, including E326K, T369M, L444P. Associations between carrier status assessed Cox survival analysis. Results A total 12.0% disease carried a variant, nearly half (22/53) them progressed to during follow-up. Carriers deleterious (adjusted hazard ratio 3.81, 95% confidence interval 1.35 10.72; P  = .011) or 1.79; 1.07 3.00;  = .028) more rapidly than noncarriers. Discussion variants are great clinical relevance disease, especially due relatively higher frequency these alleles compared other risk alleles.

参考文章(39)
Kathrin Brockmann, Karin Srulijes, Sylvia Pflederer, Ann‐Kathrin Hauser, Claudia Schulte, Walter Maetzler, Thomas Gasser, Daniela Berg, GBA-associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study Movement Disorders. ,vol. 30, pp. 407- 411 ,(2015) , 10.1002/MDS.26071
Jan Linder, Hans Stenlund, Lars Forsgren, Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study Movement Disorders. ,vol. 25, pp. 341- 348 ,(2010) , 10.1002/MDS.22987
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh, “Mini-mental state” Journal of Psychiatric Research. ,vol. 12, pp. 189- 198 ,(1975) , 10.1016/0022-3956(75)90026-6
Ignacio F. Mata, James B. Leverenz, Daniel Weintraub, John Q. Trojanowski, Alice Chen-Plotkin, Vivianna M. Van Deerlin, Beate Ritz, Rebecca Rausch, Stewart A. Factor, Cathy Wood-Siverio, Joseph F. Quinn, Kathryn A. Chung, Amie L. Peterson-Hiller, Jennifer G. Goldman, Glenn T. Stebbins, Bryan Bernard, Alberto J. Espay, Fredy J. Revilla, Johnna Devoto, Liana S. Rosenthal, Ted M. Dawson, Marilyn S. Albert, Debby Tsuang, Haley Huston, Dora Yearout, Shu-Ching Hu, Brenna A. Cholerton, Thomas J. Montine, Karen L. Edwards, Cyrus P. Zabetian, GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease. Movement Disorders. ,vol. 31, pp. 95- 102 ,(2016) , 10.1002/MDS.26359
Rita Török, Dénes Zádori, Nóra Török, Éva Csility, László Vécsei, Péter Klivényi, None, An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson’s disease Neuroscience Letters. ,vol. 610, pp. 135- 138 ,(2016) , 10.1016/J.NEULET.2015.11.001
Ziv Gan‐Or, Anat Mirelman, Ronald B. Postuma, Isabelle Arnulf, Anat Bar‐Shira, Yves Dauvilliers, Alex Desautels, Jean‐François Gagnon, Claire S. Leblond, Birgit Frauscher, Roy N. Alcalay, Rachel Saunders‐Pullman, Susan B. Bressman, Karen Marder, Christelle Monaca, Birgit Högl, Avi Orr‐Urtreger, Patrick A. Dion, Jacques Y. Montplaisir, Nir Giladi, Guy A. Rouleau, GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder Annals of clinical and translational neurology. ,vol. 2, pp. 941- 945 ,(2015) , 10.1002/ACN3.228
Corinna Vossius, Jan P. Larsen, Carmen Janvin, Dag Aarsland, The economic impact of cognitive impairment in Parkinson's disease. Movement Disorders. ,vol. 26, pp. 1541- 1544 ,(2011) , 10.1002/MDS.23661
Deborah L. Stone, Nahid Tayebi, Eduard Orvisky, Barbara Stubblefield, Victor Madike, Ellen Sidransky, Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease. Human Mutation. ,vol. 15, pp. 181- 188 ,(2000) , 10.1002/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S
Magda Montfort, Amparo Chabás, Lluïsa Vilageliu, Daniel Grinberg, Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and “modifier” polymorphisms† Human Mutation. ,vol. 23, pp. 567- 575 ,(2004) , 10.1002/HUMU.20043
S. Hoops, S. Nazem, A. D. Siderowf, J. E. Duda, S. X. Xie, M. B. Stern, D. Weintraub, Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease Neurology. ,vol. 73, pp. 1738- 1745 ,(2009) , 10.1212/WNL.0B013E3181C34B47